ProPhase Labs, Inc. Selling and Marketing Expense
ProPhase Labs, Inc. (PRPH) reported Selling and Marketing Expense of $1.29 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-31.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2021-03-31
- ProPhase Labs, Inc. selling and marketing expense for the quarter ending 2020-12-31 was $739.00K, a 459.85% increase year-over-year.
- ProPhase Labs, Inc. selling and marketing expense for the quarter ending 2020-09-30 was $253.00K, a 16.23% decline year-over-year.
- ProPhase Labs, Inc. selling and marketing expense for the quarter ending 2020-06-30 was $125.00K, a 63.45% decline year-over-year.
- ProPhase Labs, Inc. selling and marketing expense for the quarter ending 2020-03-31 was $170.00K, a 36.09% decline year-over-year.
- ProPhase Labs, Inc. selling and marketing expense for fiscal 2020 was $1.29M, a 23.51% increase from fiscal 2019.
- ProPhase Labs, Inc. selling and marketing expense for fiscal 2019 was $1.04M, a 5.87% decline from fiscal 2018.
- ProPhase Labs, Inc. selling and marketing expense for fiscal 2018 was $1.11M, a 58.37% increase from fiscal 2017.
- ProPhase Labs, Inc. selling and marketing expense for fiscal 2017 was $699.00K, a 58.88% decline from fiscal 2016.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 3 month as first filed | Selling and Marketing Expense 6 month | Selling and Marketing Expense 6 month as first filed | Selling and Marketing Expense 9 month | Selling and Marketing Expense 9 month as first filed | Selling and Marketing Expense 12 month | Selling and Marketing Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | $739.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $992.00K derived: sum of 2 quarters · filed 2021-03-31 | $1.12M derived: sum of 3 quarters · filed 2021-03-31 | $1.29M 10-K · filed 2021-03-31 | ||||
| 2020-09-30 | $253.00K 10-Q · filed 2020-11-19 | $378.00K derived: sum of 2 quarters · filed 2020-11-19 | $548.00K 10-Q · filed 2020-11-19 | $680.00K derived: sum of 4 quarters · filed 2021-03-31 | ||||
| 2020-06-30 | $125.00K 10-Q · filed 2020-08-11 | $295.00K 10-Q · filed 2020-08-11 | $427.00K derived: sum of 3 quarters · filed 2021-03-31 | $729.00K derived: sum of 4 quarters · filed 2021-03-31 | ||||
| 2020-03-31 | $170.00K 10-Q · filed 2020-05-12 | $302.00K derived: sum of 2 quarters · filed 2021-03-31 | $604.00K derived: sum of 3 quarters · filed 2021-03-31 | $946.00K derived: sum of 4 quarters · filed 2021-03-31 | ||||
| 2019-12-31 | $132.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $434.00K derived: sum of 2 quarters · filed 2021-03-31 | $776.00K derived: sum of 3 quarters · filed 2021-03-31 | $1.04M 10-K · filed 2021-03-31 | ||||
| 2019-09-30 | $302.00K 10-Q · filed 2020-11-19 | $644.00K derived: sum of 2 quarters · filed 2020-11-19 | $910.00K 10-Q · filed 2020-11-19 | $1.22M derived: sum of 4 quarters · filed 2020-11-19 | ||||
| 2019-06-30 | $342.00K 10-Q · filed 2020-08-11 | $608.00K 10-Q · filed 2020-08-11 | $913.00K derived: sum of 3 quarters · filed 2020-08-11 | $1.31M derived: sum of 4 quarters · filed 2020-08-11 | ||||
| 2019-03-31 | $266.00K 10-Q · filed 2020-05-12 | $571.00K derived: sum of 2 quarters · filed 2020-05-12 | $966.00K derived: sum of 3 quarters · filed 2020-05-12 | $1.20M derived: sum of 4 quarters · filed 2020-05-12 | ||||
| 2018-12-31 | $305.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $700.00K derived: sum of 2 quarters · filed 2020-03-26 | $935.00K derived: sum of 3 quarters · filed 2020-03-26 | $1.11M 10-K · filed 2020-03-26 | ||||
| 2018-09-30 | $395.00K 10-Q · filed 2019-11-12 | $630.00K derived: sum of 2 quarters · filed 2019-11-12 | $802.00K 10-Q · filed 2019-11-12 | $1.01M derived: sum of 4 quarters · filed 2019-11-12 | ||||
| 2018-06-30 | $235.00K 10-Q · filed 2019-08-12 | $407.00K 10-Q · filed 2019-08-12 | $620.00K derived: sum of 3 quarters · filed 2019-08-12 | $770.00K derived: sum of 4 quarters · filed 2019-08-12 | ||||
| 2018-03-31 | $172.00K 10-Q · filed 2019-05-14 | $385.00K derived: sum of 2 quarters · filed 2019-05-14 | $535.00K derived: sum of 3 quarters · filed 2019-05-14 | $756.00K derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | $213.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | $363.00K derived: sum of 2 quarters · filed 2019-03-26 | $584.00K derived: sum of 3 quarters · filed 2019-03-26 | $699.00K 10-K · filed 2019-03-26 | ||||
| 2017-09-30 | $150.00K 10-Q · filed 2018-11-14 | $371.00K derived: sum of 2 quarters · filed 2018-11-14 | $486.00K 10-Q · filed 2018-11-14 | $1.50M derived: sum of 4 quarters · filed 2018-11-14 | ||||
| 2017-06-30 | $221.00K 10-Q/A · filed 2018-08-20 | $336.00K 10-Q/A · filed 2018-08-20 | $1.35M derived: sum of 3 quarters · filed 2018-08-20 | $1.50M derived: sum of 4 quarters · filed 2018-08-20 | ||||
| 2017-03-31 | $115.00K 10-Q/A · filed 2018-08-20 | $1.13M derived: sum of 2 quarters · filed 2018-08-20 | $1.28M derived: sum of 3 quarters · filed 2018-08-20 | $1.52M derived: sum of 4 quarters · filed 2018-08-20 | ||||
| 2016-12-31 | $1.01M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2018-08-20 | $1.17M derived: sum of 2 quarters · filed 2018-08-20 | $1.40M derived: sum of 3 quarters · filed 2018-08-20 | $1.70M 10-K/A · filed 2018-08-20 | $7.08M 10-K · filed 2017-02-24 | |||
| 2016-09-30 | $153.00K 10-Q/A · filed 2018-08-20 | $676.00K 10-Q · filed 2016-11-14 | $389.00K derived: sum of 2 quarters · filed 2018-08-20 | $686.00K 10-Q/A · filed 2018-08-20 | $4.04M 10-Q · filed 2016-11-14 | -$3.23M derived: sum of 4 quarters · filed 2018-08-20 | ||
| 2016-06-30 | $236.00K 10-Q/A · filed 2018-08-20 | $769.00K 10-Q · filed 2016-08-11 | $534.00K 10-Q/A · filed 2018-08-20 | $3.37M 10-Q · filed 2016-08-11 | -$3.38M derived: sum of 3 quarters · filed 2018-08-20 | -$2.69M derived: sum of 4 quarters · filed 2018-08-20 | ||
| 2016-03-31 | $298.00K 10-Q/A · filed 2018-08-20 | $2.60M 10-Q · filed 2016-05-13 | -$3.62M derived: sum of 2 quarters · filed 2018-08-20 | -$2.92M derived: sum of 3 quarters · filed 2018-08-20 | -$2.21M derived: sum of 4 quarters · filed 2018-08-20 | |||
| 2015-12-31 | -$3.92M derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-08-20 | -$3.22M derived: sum of 2 quarters · filed 2018-08-20 | -$2.51M derived: sum of 3 quarters · filed 2018-08-20 | $303.00K 10-K/A · filed 2018-08-20 | $7.70M 10-K · filed 2016-03-29 | |||
| 2015-09-30 | $699.00K 10-Q · filed 2016-11-14 | $1.41M derived: sum of 2 quarters · filed 2016-11-14 | $4.22M 10-Q · filed 2016-11-14 | $8.46M derived: sum of 4 quarters · filed 2017-02-24 | ||||
| 2015-06-30 | $710.00K 10-Q · filed 2016-08-11 | $3.52M 10-Q · filed 2016-08-11 | $7.76M derived: sum of 3 quarters · filed 2017-02-24 | $8.64M derived: sum of 4 quarters · filed 2017-02-24 | ||||
| 2015-03-31 | $2.81M 10-Q · filed 2016-05-13 | $7.05M derived: sum of 2 quarters · filed 2017-02-24 | $7.93M derived: sum of 3 quarters · filed 2017-02-24 | $8.78M derived: sum of 4 quarters · filed 2017-02-24 | ||||
| 2014-12-31 | $4.24M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $5.12M derived: sum of 2 quarters · filed 2017-02-24 | $5.97M derived: sum of 3 quarters · filed 2017-02-24 | $8.96M 10-K · filed 2017-02-24 | ||||
| 2014-09-30 | $875.00K 10-Q · filed 2015-11-13 | $1.73M derived: sum of 2 quarters · filed 2015-11-13 | $4.72M 10-Q · filed 2015-11-13 | $9.10M derived: sum of 4 quarters · filed 2016-03-29 | ||||
| 2014-06-30 | $852.00K 10-Q · filed 2015-08-12 | $3.85M 10-Q · filed 2015-08-12 | $8.22M derived: sum of 3 quarters · filed 2016-03-29 | $9.31M derived: sum of 4 quarters · filed 2016-03-29 | ||||
| 2014-03-31 | $3.00M 10-Q · filed 2015-05-13 | $7.37M derived: sum of 2 quarters · filed 2016-03-29 | $8.46M derived: sum of 3 quarters · filed 2016-03-29 | $9.17M derived: sum of 4 quarters · filed 2016-03-29 | ||||
| 2013-12-31 | $4.38M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $5.47M derived: sum of 2 quarters · filed 2016-03-29 | $6.17M derived: sum of 3 quarters · filed 2016-03-29 | $9.54M 10-K · filed 2016-03-29 | ||||
| 2013-09-30 | $1.09M 10-Q · filed 2014-11-13 | $1.80M derived: sum of 2 quarters · filed 2014-11-13 | $5.16M 10-Q · filed 2014-11-13 | $9.08M derived: sum of 4 quarters · filed 2015-03-27 | ||||
| 2013-06-30 | $709.00K 10-Q · filed 2014-08-12 | $4.07M 10-Q · filed 2014-08-12 | $7.99M derived: sum of 3 quarters · filed 2015-03-27 | $9.02M derived: sum of 4 quarters · filed 2015-03-27 | ||||
| 2013-03-31 | $3.36M 10-Q · filed 2014-05-12 | $7.28M derived: sum of 2 quarters · filed 2015-03-27 | $8.31M derived: sum of 3 quarters · filed 2015-03-27 | $9.13M derived: sum of 4 quarters · filed 2015-03-27 | ||||
| 2012-12-31 | $3.91M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-27 | $4.95M derived: sum of 2 quarters · filed 2015-03-27 | $5.77M derived: sum of 3 quarters · filed 2015-03-27 | $8.95M 10-K · filed 2015-03-27 | ||||
| 2012-09-30 | $1.03M 10-Q · filed 2013-11-13 | $1.85M derived: sum of 2 quarters · filed 2013-11-13 | $5.03M 10-Q · filed 2013-11-13 | $9.56M derived: sum of 4 quarters · filed 2014-03-27 | ||||
| 2012-06-30 | $820.00K 10-Q · filed 2013-08-13 | $4.00M 10-Q · filed 2013-08-13 | $8.53M derived: sum of 3 quarters · filed 2014-03-27 | $9.68M derived: sum of 4 quarters · filed 2014-03-27 | ||||
| 2012-03-31 | $3.18M 10-Q · filed 2013-05-10 | $7.71M derived: sum of 2 quarters · filed 2014-03-27 | $8.86M derived: sum of 3 quarters · filed 2014-03-27 | $9.53M derived: sum of 4 quarters · filed 2014-03-27 | ||||
| 2011-12-31 | $4.53M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $5.69M derived: sum of 2 quarters · filed 2014-03-27 | $6.35M derived: sum of 3 quarters · filed 2014-03-27 | $7.90M 10-K · filed 2014-03-27 | ||||
| 2011-09-30 | $1.16M 10-Q · filed 2012-11-14 | $1.82M derived: sum of 2 quarters · filed 2012-11-14 | $3.38M 10-Q · filed 2012-11-14 | $6.53M derived: sum of 4 quarters · filed 2013-03-28 | ||||
| 2011-06-30 | $663.00K 10-Q · filed 2012-08-13 | $2.22M 10-Q · filed 2012-08-13 | $5.38M derived: sum of 3 quarters · filed 2013-03-28 | $6.28M derived: sum of 4 quarters · filed 2013-03-28 | ||||
| 2011-03-31 | $1.55M 10-Q · filed 2012-05-11 | $4.71M derived: sum of 2 quarters · filed 2013-03-28 | $5.62M derived: sum of 3 quarters · filed 2013-03-28 | $6.40M derived: sum of 4 quarters · filed 2013-03-28 | ||||
| 2010-12-31 | $3.16M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $4.06M derived: sum of 2 quarters · filed 2013-03-28 | $4.84M derived: sum of 3 quarters · filed 2013-03-28 | $5.58M 10-K · filed 2013-03-28 | ||||
| 2010-09-30 | $904.00K 10-Q · filed 2011-11-14 | $1.68M derived: sum of 2 quarters · filed 2011-11-14 | $2.42M 10-Q · filed 2011-11-14 | |||||
| 2010-06-30 | $780.00K 10-Q · filed 2011-08-12 | $1.51M 10-Q · filed 2011-08-12 | ||||||
| 2009-12-31 | $4.85M 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |